DE FEO, ALESSANDRA
DE FEO, ALESSANDRA
CENTRO INTERDIPARTIMENTALE ALMA MATER INSTITUTE ON HEALTHY PLANET
Personale esterno ed autonomi
CD99 contributes to the EWS::FLI1 transcriptome by specifically affecting FOXM1-targets involved in the G2/M cell cycle phase, thus influencing the Ewing sarcoma genetic landscape
2024 Pasello M.; Laginestra M.A.; Manara M.C.; Landuzzi L.; Ruzzi F.; Maioli M.; Pellegrini E.; De Feo A.; Lollini P.-L.; Scotlandi K.
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma
2022 Carrabotta, Marianna; Laginestra, Maria Antonella; Durante, Giorgio; Mancarella, Caterina; Landuzzi, Lorena; Parra, Alessandro; Ruzzi, Francesca; Toracchio, Lisa; De Feo, Alessandra; Giusti, Veronica; Pasello, Michela; Righi, Alberto; Lollini, Pier-Luigi; Palmerini, Emanuela; Donati, Davide Maria; Manara, Maria Cristina; Scotlandi, Katia
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity
2022 Balestra, Tommaso; Manara, Maria Cristina; Laginestra, Maria Antonella; Pasello, Michela; De Feo, Alessandra; Bassi, Cristian; Guerzoni, Clara; Landuzzi, Lorena; Lollini, Pier-Luigi; Donati, Davide Maria; Negrini, Massimo; Magnani, Mauro; Scotlandi, Katia
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
2020 Sciandra M.; De Feo A.; Parra A.; Landuzzi L.; Lollini P.-L.; Manara M.C.; Mattia G.; Pontecorvi G.; Baricordi C.; Guerzoni C.; Bazzocchi A.; Longhi A.; Scotlandi K.
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation
2019 De Feo A.; Sciandra M.; Ferracin M.; Felicetti F.; Astolfi A.; Pignochino Y.; Picci P.; Care A.; Scotlandi K.